Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis - Petrelli, F; Borgonovo, K; Cabiddu, M (Breast Cancer Res Treat, 2012)
et al.